In many places, the emergence of this sector of the economy happened spontaneously. Take, for example, Silicon Valley. Or the growth of biotechnology businesses in the greater Boston area. Our state’s leaders understood that this sector was too important to Oklahoma’s long-term economic health (and the health of our population) to ignore. So they took some farsighted steps to try to catalyze the development of science and technology in Oklahoma.
From Staff Reports Copyright © 2015 The Oklahoma Publishing Co. i2E Inc. and Accele Venture Partners recently closed a $600,000 follow-on investment in Synereca Pharmaceuticals, a portfolio company of Accele Biopharma, an Oklahoma City-based biotechnology accelerator. With the most recent investment, Synereca has now received $2.5 million in funding to support its development of compoundsRead more
By Lillie-Beth Brinkman Copyright (©) 2015, The Oklahoma Publishing Company PHILADELPHIA — By mid-day on Tuesday, people in bioscience fields from China, Texas, Japan and New Mexico had met with Justin Briggs from Oklahoma City’s Accele BioPharma Inc., at the 2015 international convention of the Biotechnology Industry Organization (BIO). Briggs was part of the OklahomaRead more
The company has developed a novel antibody platform to address significant needs in infectious diseases, including pneumococcal pneumonia which results in the hospitalization of more than 1 million people annually in the U.S. and Europe. Contact: Sarah Seagraves, Senior VP for Marketing (405) 813-2403 or email sseagraves@i2E.org i2E, Inc., and AcceleVenture Partners recently closed aRead more
